OBJECTIVE: To estimate rates of human papillomavirus (HPV) vaccination, factors
associated with intention and belief in one's ability (self-efficacy) to receive the vaccine, and …

Objective: To describe human papillomavirus (HPV) vaccine uptake, predictors of
vaccination, and barriers to vaccination in young women. Methods: Participants were 13–26 …

BACKGROUND: Human papillomavirus (HPV) vaccination is recommended to protect
against HPV-related diseases. OBJECTIVE: To estimate HPV vaccine coverage and assess …

BACKGROUND: Certain types of human papillomavirus (HPV) can cause cervical and other
cancers. A vaccine that protects against HPV types responsible for 70% of cervical cancers …

Human papillomavirus (HPV) is the most common sexually transmitted infection. It often
inflicts adolescents and young adults shortly after onset of sexual activity. More than 30 …

We assessed Canadian obstetrician/gynaecologists', family physicians' and paediatricians'
knowledge, attitudes, and beliefs about HPV infection and prevention, as well as factors …

STUDY OBJECTIVE: To assess knowledge and attitudes of young uninsured women toward
human papillomavirus (HPV) vaccination and clinical trials. DESIGN: Cross-sectional study …

Abstract Objective: In 2006, the Food and Drug Administration (FDA) approved the human
papillomavirus (HPV) vaccine Gardasil®(Merck) for girls and women aged 9–26 years …

PURPOSE: In 2006, universal human papillomavirus (HPV) vaccination of females ages 9 to
26 years became a formal recommendation, yet little is known about knowledge and …

Until recently, awareness of the sexually transmitted infection human papillomavirus—the
virus that causes cervical cancer—was relatively low. The purpose of this study was to …